Atossa Genetics to Present at Two Upcoming Investor Conferences

Marketwired

SEATTLE, WA--(Marketwired - Jan 9, 2014) - Atossa Genetics, Inc. (NASDAQ: ATOS), the Breast Health Company™, today announced that management will present at two upcoming investor conferences: Sidoti Semi-Annual Microcap Conference on Monday, January 13, 2014, at 10:00 a.m. Eastern Time, at the Grand Hyatt Hotel in New York City, and Biotech Showcase on Wednesday, January 15, 2014, at 3:00 p.m. Pacific Time, at the Parc 55 Wyndham San Francisco - Union Square in San Francisco, California.

About Atossa Genetics

Atossa Genetics, Inc. is focused on proprietary products and services related to breast health through the commercialization of medical devices and, through its wholly-owned subsidiary, The National Reference Laboratory for Breast Health, Inc., the offering of laboratory services and tests. For additional information, please visit www.atossagenetics.com.

Forward-Looking Statements

Forward-looking statements in this press release are subject to risks and uncertainties that may cause actual results to differ materially from the anticipated or estimated future results, including the risks and uncertainties associated with actions by the FDA, including timing of review by the FDA of 510(k) submissions, and actions related thereto, the outcome or timing of regulatory clearances needed by Atossa to sell its products, responses to regulatory matters, Atossa's ability to continue to manufacture and sell its products, recalls of products, the efficacy of Atossa's products and services, the market demand for and acceptance of Atossa's products and services, performance of distributors, estimated future expenses and cash needs, and other risks detailed from time to time in Atossa's filings with the Securities and Exchange Commission, including without limitation its periodic reports on Form 10-K and 10-Q, each as amended and supplemented from time to time.

Contact:


Atossa Genetics, Inc.
Kyle Guse
CFO and General Counsel
(O) 800-351-3902
Email Contact

MBS Value Partners
Matthew D. Haines
(Investors and Media)
Managing Director
(O) 212-710-9686
View Comments (0)